Ann Childress Usa diagnosing adults Patient 25 Years of ADDitude symptoms guidelines Ann Childress Usa

First-Ever Adult ADHD Guidelines Forthcoming

Reading now: 881

ADHD diagnoses among adults are growing faster than ever in the U.S. despite the absence of formal clinical guidelines for the accurate evaluation and treatment of the condition after childhood.

Finally, a task force commissioned by the American Professional Society of ADHD and Related Disorders (APSARD) is developing adult ADHD guidelines.In an interview with ADDitude, APSARD President Ann Childress, M.D., discussed the importance and implications of the first-ever U.S.

guidelines for ADHD in men and women. Here are excerpts from that interview.Why are clinical guidelines to diagnose and treat ADHD in adults necessary?Recent data published by the Centers for Disease Control and Prevention found an increase in stimulant prescriptions for adults with ADHD between 2016 and 2021.

The website is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.

Related articles
Analysis on Homeopathy for ADHD Deemed ‘Invalid,’ ‘Biased’
November 6, 2023Pediatrics Research has retracted a paper on the effectiveness of using homeopathy to treat ADHD, citing “substantial concerns regarding the validity of the results presented in this article.” 1The original article “Is Homeopathy Effective for Attention Deficit and Hyperactivity Disorder? A Meta-Analysis” reported that “individualized homeopathy showed a clinically relevant and statistically robust effect in the treatment of ADHD.”1 This retraction directly challenges those results and addresses the concerns of critics, who argue that science does not support the use of homeopathy for addressing ADHD symptoms.The journal’s editor-in-chief issued the retraction after a review found four “deficiencies,” including the following:The paper’s retraction comes more than a year after critics first questioned the validity of the studies included in the meta-analysis. Shortly after the paper’s June 2022 publication, Edzard Ernst, M.D., Ph.D., MAE, FMedSci, FRSB, FRCP, FRCPEd, asked the editors of Pediatrics Research to add a caution notice or withdraw the paper.“We conclude that the positive result obtained by the authors is due to a combination of the inclusion of biased trials unsuitable to build evidence together with some major misreporting of study outcomes,” he wrote.In a follow-up letter sent in June 2023, Ernst wrote, “In our comment, we point out that the authors made a lot of errors — to say it mildly.